A carregar...
SUN-164 Use of Metformin, Premixed Insulin, and Glucagon-Like Peptide-1 Receptor Agonist as a Therapeutic Approach for Uncontrolled Type 2 Diabetes Mellitus
Background: Large doses of basal insulin may do little to improve glycemic. Adding pre-prandial insulin increases the number of injections and complicates treatment. Simplifying medication regimen by decreasing injections may improve compliance and lead to improved Hemoglobin A1c (HbA1c). Traditiona...
Na minha lista:
| Publicado no: | J Endocr Soc |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Endocrine Society
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6553273/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-164 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|